VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 125 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $185,640 | -29.3% | 14,000 | 0.0% | 0.03% | -26.3% |
Q2 2023 | $262,500 | +30.0% | 14,000 | 0.0% | 0.04% | +22.6% |
Q1 2023 | $201,880 | -25.5% | 14,000 | 0.0% | 0.03% | -29.5% |
Q4 2022 | $270,900 | -43.7% | 14,000 | 0.0% | 0.04% | -46.3% |
Q3 2022 | $481,000 | – | 14,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
RA Capital Management | 880,284 | $41,373,000 | 0.57% |
Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |